Study examines effects of partial dose of polio vaccine on immune response

NewsGuard 100/100 Score

"A partial dose of polio vaccine was as good as a full one in providing a basic level of immunity against the crippling disease, according to a study that may offer poor countries a cheap, effective way of ensuring the disease doesn't return after it's eradicated in an area," Bloomberg reports. "In a trial among 310 babies in Cuba, a one-fifth-sized dose of the shot primed the immune systems of 94 percent of the infants for poliovirus type 2, compared with 98 percent of those who received a full dose, researchers at the World Health Organization wrote in the New England Journal of Medicine [Thursday]," the news service writes, adding, "After two doses of the partial vaccine, 98 percent of the infants were protected against type 2 polio, compared with 100 percent of those who got the regular dose, the researchers found."

"We were almost blown away by the level of priming that we saw after a single dose," Roland Sutter, a WHO researcher and one of the study's authors, said in a telephone interview with Bloomberg, adding, "We did not expect that we would see this at this level," the news service writes. Bloomberg also discusses the WHO's recommendations pertaining to polio vaccination and examines the potential implications of these findings for the costs of polio vaccination in developing countries (Bennett, 1/30).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New influenza vaccine strategies aim to enhance protection with T-cell responses